Life Science Compliance Update

July 17, 2017

This is Not Your Parent’s Compliance Program – The New Era of Compliance Resourcing at Small to Mid-Size Pharmaceutical Companies


At the 14th Annual CBI Pharmaceutical Compliance Congress held in April 2017, almost half the attendees were from small to mid-sized companies that generate $3 billion or less in annual revenue. At the same time, the compliance burdens for all pharmaceutical companies continue to increase. This article explores the output of industry experts in attendance at CBI’s small to mid-sized breakout regarding the need for minimum compliance program resources as well as survey data showing that certain companies are funding their compliance programs in line with these needed minimum resources.

In April 2017, life science compliance professionals from around the country once again made the annual pilgrimage to Washington DC for CBI’s Annual Pharmaceutical Compliance Congress. Now in its 14th year, it is one of the largest annual gatherings of such professionals in the United States. What is remarkable about this conference, is that while members from large pharmaceutical companies once accounted for the bulk of the attendance, today roughly 44% of the more than 500 attendees come from small to mid-sized companies (“SMCs”). In other words, almost half the attendees come
from companies that have $3 billion or less in annual revenue.

Given this changing demographic, CBI has expanded its SMC content offerings, including a three-part breakout addressing SMC-specific topics and challenges. At the center of this year’s SMC breakout was the challenge of compliance resourcing.

To Read the Full Story, Subscribe, Download a Sample Issue, or Sign In

June 16, 2017

Webinar on CMS Spend Submission


On Tuesday, June 20th, qordata is hosting a panel discussion webinar on “Learning From CMS Spend Submission.”

The webinar will run from 11:00 am EST – 12:00 pm EST and will include discussion from Chrissy Bradshaw of Porizo, April Pierce of Shire and Elizabeth Bodine of Merz USA. The three executives will share their experiences in implementing and working around the spend obligation.

The following topics would be covered in this Panel Discussion:

  • Best practices to follow after spend submission
  • Advanced spend data monitoring using Open Payments data
  • Identify outliers on the basis of benchmarks
  • Avoid litigations and Law suits
  • Improve compliance programs using data analytics

The agenda will cover: lessons learned by the pharmaceutical manufacturing industry from 2013 through 2017; preparation for changes in the Sunshine Payments Act; adjustments that are required in internal analytics systems; and how analytics have assisted other functions within their business.

Senior and mid-level transparency, corporate compliance and legal professionals from the pharmaceutical manufacturing industry are encouraged to attend, as are Pharma Sales Professionals interested in improving their reporting practices via technology.

If you can’t attend live we still encourage you to register for the event, as qordata will send out a recording and slides to those who are unable to attend live.

April 28, 2017

ExL Events to Host the 8th Aggregate Spend and Sunshine Act Conference


Unlock the Value of Transparent and Efficient Data Reporting to Improve the Operation of Your Organization

ExL Events will host the 8th Aggregate Spend and Sunshine Act Conference this June 15-16 at the Sonesta Philadelphia Rittenhouse Square in Philadelphia, PA.

Progressive leaders from pharmaceutical, biotechnology and medical device companies will convene for two days to discuss the value of transparency reporting and exchange tools used to translate aggregate spend data into business improvements that enhance daily efficiency. View the complete agenda and faculty list here.

This annual conference attracts delegates globally. Participants will include representatives from Pfizer, Viscadia, Alkermes, Qiagen, Sun Pharma, Foundation Medicine, Bayer Healthcare, Chiesi, Draeger Medical, Horizon Pharma, Concur, Regeneron Pharmaceuticals and Medtronic.  

Featured speakers include:

  • Michael O’Connor, Senior Director, Global Head Compliance and Ethics Operations, ALEXION PHARMACEUTICALS, INC.
  • Gretchen Reyes Cseplo, Compliance Officer, US, Canada and Global Compliance Operations, CONVATEC
  • Avi Spira, Vice President and Chief Compliance Officer, CANTEL MEDICAL CORP.
  • Ben Yao, Director, Transparency, ASTELLAS
  • Amie Phillips Pablo, Associate Director, Government Reporting, NOVO NORDISK INC.

Conference sponsors and supporting partners include: Concur, MedPro Systems, QuintilesIMS and Alanda Software.

Register now to save $200 off the standard registration rate — early bird pricing expires April 28. Please mention priority code C882PMLSCU when signing up.

ExL Events, a division of Questex, LLC, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe, Latin America and additional markets. Its experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events designed to exceed the dynamic informational and networking needs of audiences. ExL Events conference platforms facilitate the exchange of critical information between industry executives and suppliers to support their scientific and commercial goals.

For business development and sponsorship opportunities, please contact Alexander Siegel at 917-242-3893 or

For general information, please contact Tyler Lobo, Conference Production Director, at 917-242-3899 or 


Preview | Powered by FeedBlitz


July 2017
Sun Mon Tue Wed Thu Fri Sat
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31